Genzyme hires Fleishman-Hillard for corporate brief

Biotechnology firm Genzyme Therapeutics has hired its first corporate PR support in an effort to raise the company's profile in the UK.

Aoife Kilkenny
Aoife Kilkenny

Omnicom partners Fleishman-Hillard and Bernard Hodes Group have been appointed for a joint brief to handle the firm's UK corporate brand identity. The agencies fought off competition from Hanover Communications and APCO Worldwide to land the brief.

Genzyme is the world's third largest biotechnology company and specialises in rare inherited disorders, kidney disease, orthopaedics, transplants, cancer, and diagnostic testing.

The account will be handled by Fleishman-Hillard associate director Aoife Kilkenny and Bernard Hodes Group senior solutions consultant Annette Frem. They will report into Genzyme's government relations director Steve Bates.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in